Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated with Rivaroxaban and Warfarin in the ROCKET AF Trial

Jonathan P. Piccini, Susanna Stevens, Yuliya Lokhnygina, Manesh Patel, Daniel Singer, Jonathan Halperin, Graeme Hankey, Werner Hacke, Richard Becker, Christopher Nessel, Kenneth Mahaffey, Keith Fox, Robert Califf, Gunter Breithardt

    Research output: Contribution to journalAbstract/Meeting Abstract

    Original languageEnglish
    Number of pages2
    JournalCirculation
    Volume126
    Issue number21
    Publication statusPublished - 20 Nov 2012

    Cite this

    Piccini, J. P., Stevens, S., Lokhnygina, Y., Patel, M., Singer, D., Halperin, J., Hankey, G., Hacke, W., Becker, R., Nessel, C., Mahaffey, K., Fox, K., Califf, R., & Breithardt, G. (2012). Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated with Rivaroxaban and Warfarin in the ROCKET AF Trial. Circulation, 126(21).